References
- Halliwell B. Current status review: free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis. British Journal of Experimental Pathology 1989; 70: 737–757
- Esterbauer H., Striegl G., Puhl H., Rothender M. Continous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Research Communications 1989; 6: 67–75
- Knight B. L., Soutar A. K. Degradation by cultured fibroblasts and macrophages of unmodified and 1,2-cyclohexanedione-modified low-density lipoprotein from normal and homozygous familial hypercholesterolaemic subjects. Biochemical Journal 1982; 202: 145–152
- Redgrave T. G., Roberts D. C.K., West C. E. Separation of plasma lipoproteins by density gradient ultracentrifugation. Analytical Biochemistry 1975; 65: 42–49
- Regnström J., Nilsson J., Tornvall P., Landou C., Hamsten A. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992; 339: 1183–1186
- Lowry O., Rosenbrough N., Farr A., Randall R. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
- Carlson K. Lipoprotein fractionation. Journal of Clinical Pathology 1973; 5: 32–37
- Noble R. P. Electrophoretic separation of plasma lipoproteins in agarose gel. Journal of Lipid Research 1968; 9: 693–700
- Yagi K. Short communications. A simple fluorometric assay for lipoperoxide in blood plasma. Biochemical Medicine 1976; 15: 212–216
- Lang J. K., Gohil K., Packer L. Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Analytical Biochemistry 1986; 157: 106–116
- Chou P. P., Jaynes P. K., Balley J. L. Determination of vitamin E in microsamples of serum by liquid chromatography with electrochemical detection. Clinical Chemistry 1985; 31: 880–882
- McFarlane A. S. Labelling of plasma proteins with radioactive iodine. Biochemical Journal 1956; 62: 135–143
- Thyberg J. Internalization of cationized ferritin into the Golgi complex of cultured mouse peritoneal macrophages. Effects of colchicine and cytochalasin B. European Journal of Cell Biology 1980; 23: 95–103
- Stringer M. D., Görög P. G., Freeman A., Kakkar V. V. Lipid peroxides and atherosclerosis. British Medical Journal 1989; 298: 281–284
- Liu K., Cuddy T. E., Pierce G. N. Oxidative status of lipoproteins in coronary disease patients. American Heart Journal 1992; 123: 285–290
- Sato Y., Hotta N., Sakamoto N., Matsuoka S., Ohishi N., Yagi K. Lipid peroxide level in plasma of diabetic patients. Biochemical Medicine 1979; 21: 104–107
- Uysal M., Buler H., Sener D., Oz H. Lipid peroxidation in patients with essential hypertension. International Journal of Clinical Pharmacological Research 1986; 24: 474–476
- Arshad M. A.Q., Bhadra S., Cohen R. M., Subbiah T. R. Plasma lipoprotein peroxidation potential: a test to evaluate individual susceptibility to peroxidation. Clinical Chemistry 1991; 37: 1756–1758
- Frei B., Stocker R., Ames B. N. Antioxidant detences and lipid peroxidation in human blood plasma. Proceedings of the National Academy of Sciences of the United States of America 1988; 85: 9748–9752
- Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. New England Journal of Medicine 1989; 320: 915–925
- Carew T. E., Schwenke D. C., Steinberg D. Antiatherogenic effects of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic (WHHL) rabbit. Proceedings of the National Academy of Sciences of the United States of America 1987; 84: 7725–7729
- Kita T., Nagano Y., Yokode M., Ishii K., Kume N., Ooshima A., Yoshida H., Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proceedings of the National Academy of Sciences of the United States of America 1987; 84: 5928–5931
- Ylä-Herttuala S., Palinsky W., Rosenfeld M. E., Parthasarathy S., Carew T. E., Butler S., Wiztum J. L. Evidence for presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. Journal of Clinical Investigation 1989; 84: 1086–1095
- Riemersma R. A., Wood D. A., Macintyre C. C.A., Elton R. A., Gey K. F., Oliver M. F. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991; 337: 1–5